YMFCF yields 2.10% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, YMFCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YMFCF + PFE for your $10,000?
Yamashin-Filter Corp. operates as a filter manufacturer. The company manufactures, develops, and sells filters for construction and agricultural machines, drive-train, fuel systems and various filter products for industrial and precision machines, and industrial filter related parts; and nano filter products. Its construction machinery filters include hydraulic fluid filters to protect hydraulic cylinders, controls, and hydraulic systems used on machinery; engine oil filters that are used in various types of engines to remove contaminants from oil; fuel filters used to construction machinery to remove contaminants and water from diesel fuel; transmission filters for on-highway/off-highway applications; industrial filters to filter hydraulic fluid, lubricating oil, and other liquids in a range of industrial machinery; and process filters, which are used for filtration and separation in manufacturing processes across a range of industries, including electronic parts, precision components, LCD displays, and food products. The company also provides various types of air filters for a range of settings, such as office buildings, factories, machines, and vehicles; and medical-grade masks and replacement inner sheets that are made using YAMASHIN NANO FILTER. It operates in Japan, Asia, North America, and Europe. The company was formerly known as Yamashin Industry Inc. and changed its name to Yamashin-Filter Corp. in October 2005. Yamashin-Filter Corp. was incorporated in 1956 and is headquartered in Yokohama, Japan.
Full YMFCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.